Androgen receptors and lichen sclerosus.

[1]  M. Mihm,et al.  Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2]  M. Mihm,et al.  Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. , 1998, Human pathology.

[3]  M. Sideri,et al.  Topical testosterone in the treatment of vulvar lichen sclerosus , 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  B. Smoller,et al.  "Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[5]  P. Carli,et al.  Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. , 1993, The Journal of reproductive medicine.